Cargando…
Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics
Prostate, bladder and kidney cancer are the three most common types of genitourinary cancer in the world. Of these, prostate and bladder cancers are within the top 10 most common cancers in men. Notably, kidney cancer causes no obvious symptoms in the early stages. To satisfy clinical-management req...
Autores principales: | Chen, Yi-Ting, Tsai, Cheng-Han, Chen, Chien-Lun, Yu, Jau-Song, Chang, Ying-Hsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296213/ https://www.ncbi.nlm.nih.gov/pubmed/30987711 http://dx.doi.org/10.1016/j.jfda.2018.09.005 |
Ejemplares similares
-
Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers
por: Chen, Yi-Ting, et al.
Publicado: (2019) -
Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens
por: Tsai, Cheng-Han, et al.
Publicado: (2018) -
Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007) -
Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
por: Ryu, Joohyun, et al.
Publicado: (2021) -
Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease
por: Chang, Chiz-Tzung, et al.
Publicado: (2015)